Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
601 JPY | +0.33% | +0.84% | -16.06% |
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- With a 2024 P/E ratio at 21.79 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Internet Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.06% | 83.5M | - | ||
+28.20% | 439B | B | ||
+33.52% | 280B | D+ | ||
+18.81% | 153B | A- | ||
+9.68% | 94.79B | C- | ||
+28.05% | 92.08B | B+ | ||
+67.89% | 62.57B | B- | ||
+16.34% | 47.05B | C+ | ||
+24.79% | 37.13B | C+ | ||
-11.16% | 31.71B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 6095 Stock
- Ratings MedPeer,Inc.